A scientific day dedicated to the latest developments in diagnosing and treating Parkinson's disease and movement disorders was recently held at the Irena Hotel in Setif, Algeria. The Turkish Medipol Hospitals Group organized the event, which brought together Algerian doctors, particularly from Setif and surrounding areas. The meeting facilitated direct discussions between these Algerian medical professionals and Professor Ali Zireh regarding advancements in Parkinson's care. Emphasis was placed on cases where medication alone proves insufficient for effective treatment. During the scientific day, modern therapeutic options and clinical trials relevant to movement disorders were thoroughly reviewed, providing attendees with a full overview of current and emerging treatments.
Advanced Treatment Options Explored
Deep Brain Stimulation (DBS) is a technique that involves implanting micro-electrodes in specific brain areas to modulate electrical activity associated with movement disorders. The Medipol Hospitals Group's specialized center for Parkinson's and movement disorders utilizes DBS, which necessitates precise patient evaluation before surgery and careful post-operative device calibration. This intricate procedure requires a multidisciplinary approach to ensure optimal outcomes for patients suffering from severe motor symptoms. Another advanced option discussed is Magnetic Resonance-guided Focused Ultrasound (MRgFUS), a non-surgical technique used to target specific brain areas for patients experiencing movement disorders and tremors. MRgFUS can serve as an alternative for patients who do not benefit sufficiently from medication or are not suitable for certain surgical interventions. The discussion noted the growing importance of non-invasive options for patients who may not be candidates for traditional surgery, broadening the scope of available treatments.
Expert Insights and Experience
Professor Ali Zireh, a specialist in movement disorder and Parkinson's surgery, was a key participant in the scientific day. He shared his extensive experience in functional neurosurgery, which spans 30 years of clinical and surgical practice. Professor Zireh has an established record in advanced neurological procedures, having performed over 1450 Deep Brain Stimulation surgeries. His participation offered Algerian medical professionals direct insight into the practical application of these advanced treatments and patient selection criteria. Professor Zireh's expertise contributed to the discussions on managing complex Parkinson's cases and exploring surgical interventions when conventional medication proves insufficient. His detailed presentations covered the nuances of patient assessment, surgical planning, and post-operative management, drawing from his vast experience in the field. The insights provided were invaluable for local practitioners seeking to enhance their understanding of these highly specialized procedures.
Medipol's International Reach
Nour El Houda Ouissi serves as the supervisor for Medipol Hospitals in the North Africa region. The Medipol Hospitals Group has previously reported treating international patients for Parkinson's disease. This includes Algerian patients who have traveled to Turkey and undergone Deep Brain Stimulation (DBS) surgeries at their facilities. These cases show Medipol's engagement with patients beyond Turkey's borders, particularly in advanced neurological treatments like DBS. The group has actively announced receiving patients from outside Turkey for Parkinson's treatment, demonstrating their commitment to providing specialized care on a global scale. This international patient flow notes the trust placed in Medipol's expertise and advanced medical infrastructure for complex neurological conditions.
Future Cooperation and Exchange
The meeting aims to open cooperation channels between doctors in Algeria and Turkey, fostering the exchange of expertise and knowledge in the field of Parkinson's treatment. Discussions during the event reviewed modern therapeutic options and clinical trials relevant to movement disorders. This exchange is intended to facilitate continued collaboration and shared learning between medical professionals from both countries. The focus on advanced treatments and ongoing research initiatives provided a platform for participants to explore further joint efforts. Such collaborations are key for advancing medical knowledge and ensuring that patients in Algeria have access to the latest and most effective treatments for Parkinson's disease and other movement disorders. The scientific day served as a foundational step towards building a lasting partnership in medical innovation and patient care.